One Wealth Advisors LLC Sells 25 Shares of McKesson Co. (NYSE:MCK)

One Wealth Advisors LLC lowered its position in shares of McKesson Co. (NYSE:MCK) by 1.1% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,246 shares of the company’s stock after selling 25 shares during the quarter. One Wealth Advisors LLC’s holdings in McKesson were worth $1,112,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Wolff Wiese Magana LLC lifted its holdings in shares of McKesson by 742.9% during the third quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock worth $29,000 after buying an additional 52 shares in the last quarter. Transform Wealth LLC lifted its holdings in shares of McKesson by 2.7% during the third quarter. Transform Wealth LLC now owns 21,030 shares of the company’s stock worth $10,412,000 after buying an additional 552 shares in the last quarter. Vontobel Holding Ltd. lifted its holdings in shares of McKesson by 1.1% during the third quarter. Vontobel Holding Ltd. now owns 78,407 shares of the company’s stock worth $38,766,000 after buying an additional 861 shares in the last quarter. McKinley Carter Wealth Services Inc. lifted its holdings in shares of McKesson by 1.8% during the third quarter. McKinley Carter Wealth Services Inc. now owns 13,687 shares of the company’s stock worth $6,767,000 after buying an additional 248 shares in the last quarter. Finally, Kapitalo Investimentos Ltda lifted its holdings in shares of McKesson by 68.5% during the third quarter. Kapitalo Investimentos Ltda now owns 723 shares of the company’s stock worth $357,000 after buying an additional 294 shares in the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

Wall Street Analysts Forecast Growth

MCK has been the subject of a number of research reports. StockNews.com downgraded McKesson from a “buy” rating to a “hold” rating in a report on Friday, September 27th. Argus boosted their price target on McKesson from $570.00 to $670.00 and gave the company a “buy” rating in a research note on Monday, June 24th. Wells Fargo & Company dropped their price target on McKesson from $576.00 to $535.00 and set an “equal weight” rating for the company in a research note on Friday, September 13th. Baird R W downgraded McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 24th. Finally, Citigroup dropped their price target on McKesson from $670.00 to $630.00 and set a “buy” rating for the company in a research note on Tuesday, September 10th. Five equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $610.86.

McKesson Trading Up 0.1 %

NYSE MCK traded up $0.71 during trading on Thursday, hitting $511.64. 59,852 shares of the company’s stock were exchanged, compared to its average volume of 803,982. The company has a market cap of $66.48 billion, a PE ratio of 22.83, a P/E/G ratio of 1.17 and a beta of 0.44. The stock’s 50 day moving average price is $522.51 and its two-hundred day moving average price is $552.42. McKesson Co. has a fifty-two week low of $431.35 and a fifty-two week high of $637.51.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, August 7th. The company reported $7.88 earnings per share for the quarter, topping the consensus estimate of $7.21 by $0.67. The company had revenue of $79.28 billion for the quarter, compared to analysts’ expectations of $82.53 billion. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business posted $7.27 earnings per share. Analysts forecast that McKesson Co. will post 32.07 earnings per share for the current fiscal year.

McKesson Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, October 1st. Shareholders of record on Monday, September 2nd were given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a yield of 0.56%. The ex-dividend date of this dividend was Friday, August 30th. This is an increase from McKesson’s previous quarterly dividend of $0.62. McKesson’s dividend payout ratio is currently 12.69%.

Insider Buying and Selling at McKesson

In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $561.10, for a total transaction of $2,105,808.30. Following the completion of the sale, the chief executive officer now owns 78,586 shares of the company’s stock, valued at approximately $44,094,604.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.11% of the company’s stock.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.